Morgan Stanley Apyx Medical Corp Transaction History
Morgan Stanley
- $1.27 Trillion
- Q2 2024
A detailed history of Morgan Stanley transactions in Apyx Medical Corp stock. As of the latest transaction made, Morgan Stanley holds 17,293 shares of APYX stock, worth $21,270. This represents 0.0% of its overall portfolio holdings.
Number of Shares
17,293
Previous 19,946
13.3%
Holding current value
$21,270
Previous $27,000
14.81%
% of portfolio
0.0%
Previous 0.0%
Shares
18 transactions
Others Institutions Holding APYX
# of Institutions
55Shares Held
14.3MCall Options Held
360KPut Options Held
1K-
Archon Capital Management LLC Seattle, WA3.12MShares$3.83 Million3.44% of portfolio
-
Royce & Associates LP2.5MShares$3.07 Million0.03% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.48MShares$1.82 Million0.0% of portfolio
-
Invenire Partners, LP Ridgefield, CT946KShares$1.16 Million100.0% of portfolio
-
Horizon Kinetics Asset Management LLC615KShares$756,4500.02% of portfolio
About Apyx Medical Corp
- Ticker APYX
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 34,573,000
- Market Cap $42.5M
- Description
- Apyx Medical Corporation, an energy technology company, develops, manufactures, and sells medical devices in the cosmetic and surgical markets worldwide. The company operates in two segments, Advanced Energy and Original Equipment Manufacturing (OEM). It offers Helium Plasma Generator for delivery of RF energy and helium to cut, coagulate and ab...